MedTrace Logo

Platelet-rich Fibrin With 1.2% Rosuvastatin in Chronic Periodontitis Treatment

NCT02645227 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2016-01-05

No results posted yet for this study

Summary

The present study is designed to evaluate the combined efficacy of Platelet Rich Fibrin (PRF) and 1.2% Rosuvastatin (RSV) with open flap debridement (OFD) in treatment of intrabony defects in chronic periodontitis patients

Conditions

  • Chronic Periodontitis

Interventions

PROCEDURE

Open flap debridement (OFD)

Oral prophylaxis followed by OFD for treating bone defect

PROCEDURE

OFD with Platelet rich fibrin (PRF)

Oral prophylaxis followed by OFD with PRF placement into the bone defect

PROCEDURE

OFD with PRF and 1.2% Rosuvastatin

Oral prophylaxis followed by OFD with PRF and 1.2% Rosuvastatin placement into the bone defect

Sponsors & Collaborators

  • Government Dental College and Research Institute, Bangalore

    lead OTHER

Principal Investigators

  • Avani Pradeep, MDS · Government Dental Colleege & Research Institute, Bangalore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02645227 on ClinicalTrials.gov